This observation is further supported by the observation that fascin, an organizational protein that bundles actin in cells [38] and highly expressed in colorectal adenocarcinomas and in patients with inflammatory bowel disease [3], [38] was up-regulated following rifaximin treatment. This evidence concerns the gene FSCN1 and colorectal adenocarcinoma.